Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 126

1.

SU-F-T-261: Reconstruction of Initial Photon Fluence Based On EPID Images.

Seliger T, Czarnecki D, Kussaether R, Maeder U, Engenhart-Cabillic R, Poppe B, Zink K.

Med Phys. 2016 Jun;43(6):3522. doi: 10.1118/1.4956401.

PMID:
28046547
2.

Patient's quality of life after high-dose radiation therapy for thoracic carcinomas : Changes over time and influence on clinical outcome.

Schröder C, Engenhart-Cabillic R, Vorwerk H, Schmidt M, Huhnt W, Blank E, Sidow D, Buchali A.

Strahlenther Onkol. 2016 Oct 27. [Epub ahead of print]

PMID:
27787567
3.

Changes in pulmonary function and influencing factors after high-dose intrathoracic radio(chemo)therapy.

Schröder C, Engenhart-Cabillic R, Vorwerk H, Schmidt M, Huhnt W, Blank E, Sidow D, Buchali A.

Strahlenther Onkol. 2016 Oct 25. [Epub ahead of print]

PMID:
27783103
4.

New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study Group.

Kriz J, Baues C, Engenhart-Cabillic R, Haverkamp U, Herfarth K, Lukas P, Schmidberger H, Marnitz-Schulze S, Fuchs M, Engert A, Eich HT.

Strahlenther Onkol. 2016 Sep 27. [Epub ahead of print]

PMID:
27678010
5.

A lot to a little or a little to a lot-which dose-volume relationship ensures the best clinical outcome in the high dose radiation therapy of thoracic tumors? A prospective approach.

Schröder C, Engenhart-Cabillic R, Vorwerk H, Schmidt M, Huhnt W, Blank E, Sidow D, Buchali A.

J Thorac Dis. 2016 Aug;8(8):2053-60. doi: 10.21037/jtd.2016.07.92.

6.

Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG).

Kriz J, Baues C, Engenhart-Cabillic R, Haverkamp U, Herfart K, Lukas P, Plütschow A, Schmidberger H, Staar S, Fuchs M, Engert A, Eich HT.

Strahlenther Onkol. 2016 Sep 5. [Epub ahead of print]

PMID:
27596217
7.

Dosimetric comparisons of carbon ion treatment plans for 1D and 2D ripple filters with variable thicknesses.

Ringbæk TP, Weber U, Santiago A, Simeonov Y, Fritz P, Krämer M, Wittig A, Bassler N, Engenhart-Cabillic R, Zink K.

Phys Med Biol. 2016 Jun 7;61(11):4327-41. doi: 10.1088/0031-9155/61/11/4327.

PMID:
27203127
8.

Cancer cell motility is affected through 3D cell culturing and SCF/c-Kit pathway but not by X-irradiation.

Eberle F, Saulich MF, Leinberger FH, Seeger W, Engenhart-Cabillic R, Dikomey E, Hänze J, Hattar K, Subtil FS.

Radiother Oncol. 2016 Jun;119(3):537-43. doi: 10.1016/j.radonc.2016.04.036.

PMID:
27178146
9.

Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?

Santiago A, Barczyk S, Jelen U, Engenhart-Cabillic R, Wittig A.

Radiat Oncol. 2016 May 6;11:67. doi: 10.1186/s13014-016-0643-5.

10.

Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial.

Teymoortash A, Pfestroff A, Wittig A, Franke N, Hoch S, Harnisch S, Schade-Brittinger C, Hoeffken H, Engenhart-Cabillic R, Brugger M, Strauch K.

PLoS One. 2016 Mar 18;11(3):e0151316. doi: 10.1371/journal.pone.0151316.

11.

Changes in the radiological depth correlate with dosimetric deterioration in particle therapy for stage I NSCLC patients under high frequency jet ventilation.

Santiago A, Fritz P, Mühlnickel W, Engenhart-Cabillic R, Wittig A.

Acta Oncol. 2015;54(9):1631-7. doi: 10.3109/0284186X.2015.1067716.

PMID:
26228661
12.

Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.

Ziemann F, Arenz A, Preising S, Wittekindt C, Klussmann JP, Engenhart-Cabillic R, Wittig A.

Am J Cancer Res. 2015 Feb 15;5(3):1017-31.

13.

Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.

Kriz J, Reinartz G, Dietlein M, Kobe C, Kuhnert G, Haverkamp H, Haverkamp U, Engenhart-Cabillic R, Herfarth K, Lukas P, Schmidberger H, Staar S, Hegerfeld K, Baues C, Engert A, Eich HT.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):46-53. doi: 10.1016/j.ijrobp.2015.01.048.

PMID:
25863753
14.

Assessment of potential advantages of relevant ions for particle therapy: a model based study.

Grün R, Friedrich T, Krämer M, Zink K, Durante M, Engenhart-Cabillic R, Scholz M.

Med Phys. 2015 Feb;42(2):1037-47. doi: 10.1118/1.4905374.

PMID:
25652516
15.

In reply to Weiss et al.

Fokas E, Henzel M, Engenhart-Cabillic R.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1259-60. doi: 10.1016/j.ijrobp.2014.08.001. No abstract available.

PMID:
25539377
16.

Optimization of the stopping-power-ratio to Hounsfield-value calibration curve in proton and heavy ion therapy.

Witt M, Weber U, Kellner D, Engenhart-Cabillic R, Zink K.

Z Med Phys. 2015 Sep;25(3):251-63. doi: 10.1016/j.zemedi.2014.11.001.

PMID:
25497583
17.

Dosimetric robustness against setup errors in charged particle radiotherapy of skull base tumors.

Ammazzalorso F, Jelen U, Engenhart-Cabillic R, Schlegel W.

Radiat Oncol. 2014 Dec 5;9:279. doi: 10.1186/s13014-014-0279-2.

18.

Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.

Wiegel T, Bartkowiak D, Bottke D, Thamm R, Hinke A, Stöckle M, Rübe C, Semjonow A, Wirth M, Störkel S, Golz R, Engenhart-Cabillic R, Hofmann R, Feldmann HJ, Kälble T, Siegmann A, Hinkelbein W, Steiner U, Miller K.

Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):288-94. doi: 10.1016/j.ijrobp.2014.09.039.

PMID:
25445556
19.

Making the right software choice for clinically used equipment in radiation oncology.

Vorwerk H, Zink K, Wagner DM, Engenhart-Cabillic R.

Radiat Oncol. 2014 Jun 23;9:145. doi: 10.1186/1748-717X-9-145.

20.

The influence of the local effect model parameters on the prediction of the tumor control probability for prostate cancer.

Chanrion MA, Sauerwein W, Jelen U, Wittig A, Engenhart-Cabillic R, Beuve M.

Phys Med Biol. 2014 Jun 21;59(12):3019-40. doi: 10.1088/0031-9155/59/12/3019.

PMID:
24842293
Items per page

Supplemental Content

Loading ...
Support Center